
Closed
Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative
Funding for genomics innovation partnerships
Last Update: April 9, 2026
Funding available
$ 100,000 - $ 2,000,000
Timeline
- Closing date : March 17, 2025
Location
Alberta, Manitoba, Saskatchewan, Canada
Overview
This program supports public-private genomics and biotechnology R&D partnerships in Canada, with up to $2 million in Genome Canada funding. It targets innovation, commercialization, and projects that can generate social and economic benefits.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Develop a new product or service
- Conduct research and development activities
Eligible Funding
- Maximum amount : 2,000,000 $
- Minimum amount : 100,000 $
- Up to 33% of project cost
Timeline
- Closing date : March 17, 2025
Eligible candidates
Eligible Industries
- Manufacturing
- Professional, scientific and technical services
- Health care and social assistance
Location
- Alberta, Manitoba, Saskatchewan
Legal structures
- Non-profit
- Public or Parapublic institution
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Indigenous Peoples
- Persons with Disabilities
- Other Racialized Persons
- Black Canadians
- 2SLGBTQI+
- Canadians
- Women
Non-profit candidates
Sector of operation
- Higher Education
- Research
- Hospitals and Rehabilitation
- Other Health Services
- Economic, Social and Community Development
Target groups
- Indigenous peoples
- People with disabilities
- Women & girls
- LGBTQ+ community
- Business owners / entrepreneurs
- Academia / students
- Minority groups
Revenue structures
- All structures
Scope
- Municipal
- Regional
- Provincial
- National
- International
Next steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Innovation research and development from invention to prototype demonstration
- Development of genomics and biotechnology products, processes, or services
- Commercialization-oriented public-private R&D projects
Documents Needed
- Letter of intent
- Full application
- Project research, development, and commercialization plan
- Project budget
- Data release and resource sharing plan
Eligibility
Who is eligible?
- Canadian university or college researchers
- Affiliated non-commercial research entities such as hospitals and research institutes
- Canadian for-profit entities
- Foreign for-profit entities with business operations in Canada
- Industry consortia and selected non-profit organizations
Who is not eligible
- Discovery research projects
- Commercial launches of already developed technology
- Low-risk R&D suited to capital markets
- Projects or services normally funded solely by the receptor
Eligible expenses
- Project equipment items up to $100,000 each, subject to program limits
- External services needed for the project, subject to program limits
Ineligible Costs and Activities
- Discovery research
- Commercial launches of already developed technology
- Low-risk R&D that can be serviced by capital markets
- Projects or services normally funded solely by the receptor
Eligible geographic areas
- Canada
Processing and Agreement
- Letter of intent is reviewed first for eligibility
- Eligible full applications are reviewed by external experts
- The Genome Canada Oversight and Review Committee reviews the expert assessments
- The Board of Directors makes the final funding decision
- Funded projects must submit periodic progress information and reports
Additional information
- Applicants must acknowledge that all flow-of-funds conditions, including contribution and IP agreements, must be secured by March 17, 2025 at 9:00 AM EDT.
- Projects involving Indigenous research should include a plan for engagement and follow relevant ethical and OCAP principles.
- Genome Canada’s data release and resource sharing policies apply, and an exemption may be requested in some cases.
- Funding release depends on a legally binding IP agreement signed by all concerned parties.
Contacts
Frequently Asked Questions about the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative Program
Here are answers to the most common questions about the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative?
This program supports public-private genomics and biotechnology R&D partnerships in Canada, with up to $2 million in Genome Canada funding. It targets innovation, commercialization, and projects that can generate social and economic benefits.
How much funding can be received?
Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative Funds up to 33% of admissible expenses, capped at $2,000,000 per project.
Who is eligible for the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative program?
To be eligible for the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative program, you must:
Innovation R&D project
Researcher and receptor partnership
Canadian social or economic benefit
What expenses are eligible under Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative?
Innovation research and development from invention to prototype demonstration
Development of genomics and biotechnology products, processes, or services
Commercialization-oriented public-private R&D projects
Who can I contact for more information about the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative?
You can contact Genome Canada by email at none or by phone at none.
Where is the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative available?
The Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative program is available the province of Alberta, Manitoba, Saskatchewan.
Is the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative a grant, loan, or tax credit?
Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative is a Researchers And Facilities
More programs like this
Women in STEM Scholarship$2,500-$2,500
Genomic Applications Partnership Program (GAPP) — Alberta$300,000-$2,000,00033.333336%
Alberta Innovates — Industry Commercialization AssociatesMax $120,00075%
Regional Artificial Intelligence Initiative (RAII) in the Prairie Provinces$250,000-$5,000,00050%